📖 Approx. 3 min / Updated: 2026.07.03
In this article, a medical industry-specialized M&A advisor will explain from a practical perspective what points become relevant for earn-outs in business succession and medical M&A for pulmonology. We will provide specific countermeasures based on home oxygen therapy patients, bronchoscope equipment, performance-linked consideration, and risk sharing.
1. Industry Background of Pulmonology Earn-outs
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the management environment for medical institutions, including pulmonology, has become increasingly severe in recent years due to complex factors such as medical fee revisions, soaring personnel costs, and equipment investment burdens. Particularly from the perspective of home oxygen therapy patients and bronchoscope equipment, interest in third-party succession M&A is growing.
At the same time, earn-outs are an important point in medical M&A practice. By appropriately designing performance-linked consideration and risk sharing, a succession beneficial to both the transferor and transferee can be achieved.
2. Key Practical Points
- Preparation: Organize the unique operational flow, patient base, and equipment status specific to pulmonology, and clarify the transfer conditions.
- Business Valuation: Calculate an appropriate transfer consideration range based on the specialty’s characteristics. For pulmonology, home oxygen therapy patients and bronchoscope equipment are key valuation factors.
- Earn-out Design: Select the optimal scheme based on performance-linked consideration and risk sharing. Verification from tax, legal, and labor perspectives is also necessary.
- Partner Search & Matching: Select potential transferees suitable for the specialty’s characteristics from a nationwide network. Carefully proceed with aligning desired conditions.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and medical practice perspectives. Also confirm licenses, permits, and facility standards specific to pulmonology.
- Final Agreement & Closing: Conclude the final agreement, including representations and warranties, and indemnity clauses. Proceed concurrently with license/permit transfer and staff notification.
3. Specific Considerations in Pulmonology
In M&A for pulmonology medical institutions, home oxygen therapy patients and bronchoscope equipment hold the key to successful succession. Numerous individual points exist corresponding to the specialty’s characteristics, such as the continuity of the patient base, maintaining employment for staff (doctors, nurses, paramedical staff), equipment condition and renewal plans, and maintaining/acquiring facility standards.
Furthermore, strategic design based on market characteristics unique to pulmonology, such as the composition of insured and self-pay medical services, the status of regional medical collaboration, and relationships with nearby competing medical institutions, is crucial. Leveraging our track record in supporting pulmonology successions, our company provides practical support from an industry-specific perspective.
4. Earn-out Practical Details
Earn-outs are an area requiring specialized consideration in medical M&A. Design based on performance-linked consideration and risk sharing is key to success.
- Confirmation of Related Laws and Practical Standards: Preparation based on Medical Act, tax laws, and labor laws.
- Collaboration with Experts: Cooperation with certified public accountants, tax accountants, lawyers, and labor and social security attorneys.
- Risk Assessment: Identification of potential risks and formulation of countermeasures.
- Consensus Building Between Parties: Designing conditions satisfactory to both the transferor and transferee.
- Proper Documentation: Clear specification in the basic agreement and final contract.
Frequently Asked Questions
Q. What documents are required for consultation?
A. It would be smoother if you could prepare the financial statements for the last three fiscal years, patient number trends, staff composition, equipment list, and lease agreements (if applicable) in advance. We will receive them after the NDA is signed.
Q. What is the market price range for transferring a pulmonology practice?
A. For pulmonology, home oxygen therapy patients and bronchoscope equipment are key valuation factors. For clinics without beds, the guideline is 0.5 to 1.5 times annual revenue, and for hospitals with beds, it’s 3 to 7 times EBITDA. We will provide details in a free preliminary assessment.
Q. What are the points to note when proceeding with an earn-out?
A. Prior design based on performance-linked consideration and risk sharing is essential. Seamless execution of practical matters through expert collaboration is key to success.
Q. Will staff and patients know about the consultation?
A. Information will be disclosed only after an NDA is signed, and no disclosure to stakeholders will be made before the final agreement. We ensure strict confidentiality.
Related Columns
- Complete Guide to Hospital/Medical Corporation Business Succession | Medical M&A Practice from Successor Shortage to Success Stories
- Complete Guide to Clinic Sale/Transfer | Medical M&A Experts Explain Price Ranges, Procedures, and Key Considerations
- How to Proceed with Medical M&A and Hospital Succession | Explaining 6 Steps from Consultation to Agreement with Case Studies
- Complete Guide to Medical Corporation M&A Tax Schemes | Key Points for Tax Accountants and CPAs
For Pulmonology Earn-out Consultations, Contact M&A Medical
Strict Confidentiality, Free Initial Consultation, Success-Based Fee